Yanhua Sarah Hu, PhD

Bristol-Myers Squibb
Princeton, NJ, United States

Sarah obtained her Ph.D. of computational biology from Carnegie Mellon University. She has been a bioinformatics scientist in Bristol-Myers Squibb for 15 years, and is currently a scientific senior director leading clinical biomarker analyses.

Presentation(s):

• 1507: Pharmacodynamic Changes in SLE Relevant Gene Expression Induced by Deucravacitinib in Patients Enrolled in the Phase 2 PAISLEY Trial

  Monday, November 13, 2023
  9:00 AM – 11:00 AM PT

  Disclosure information not submitted.